Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2026

Mar 4, 2026

3535_dva_2026-03-04_20da6fdb-55d0-438e-b2ea-220496f79e7d.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

abt
AQUA BIO TECHNOLOGY ASA
Press Release
04 March 2026 11:18:00 CET

Aqua Bio Technology ASA: Share capital increase registered

Reference is made to the resolution by the extraordinary general meeting of Aqua Bio Technology ASA (the "Company") on 16 February 2026, regarding a share capital increase of NOK 10.0 million. The share capital increase mentioned above has now been registered with the Norwegian Register of Business Enterprises. The new share capital of the Company is NOK 26,139,675 divided by 5,227,935 shares, each with a par value of NOK 5.00.

Contacts

Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA

Phone: +47 9509 2322
Email: [email protected]

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-04 11:18 CET.

Aqua Bio Technology • Fornebuveien 37 • N-1366 Lysaker